Seven Wisconsin employers filed WARN notices in January, yet the state's unemployment rate held steady at a low 3.1%. Economists point to a cooling but stable labor market, with significant workforce changes driven by retirements and sectoral shifts.
U.S. stock futures pointed to a lower open Monday as investors braced for a flood of corporate earnings and crucial labor market reports that could sway Federal Reserve policy expectations.
If confirmed, incoming Fed Chair Kevin Warsh will inherit a booming yet bifurcated economy. Despite strong GDP growth and a surging stock market, stagnant hiring and sinking consumer confidence present a policy puzzle where interest rate cuts may offer no easy fix.
Initial unemployment filings in Missouri fell by nearly 25% last week, outpacing a modest national decline and contrasting with volatile swings in other states.
Marketing technology firm Zeta Global announces a strategic collaboration with OpenAI, aiming to deeply integrate advanced AI into its platform. The move, coupled with positive buzz from CES 2026, sharpens its competitive edge in a sector dominated by giants like Salesforce and Adobe.
The U.S. labor market faced its toughest year since the pandemic in 2025, with layoffs soaring to 1.2 million. Economists warn of an 'uncomfortably slow' rebound in 2026, leaving job seekers navigating a landscape of fierce competition and hiring freezes.
Germany's unemployment rolls swelled past 3 million in January, pushing the jobless rate to 6.6%, marking the highest January figure in a decade and signaling persistent weakness in Europe's largest economy.
Initial unemployment filings in Pennsylvania fell last week, contributing to a stable national picture, though sharp swings in other states highlight ongoing regional volatility.
Disney's newly appointed Chief Marketing and Brand Officer, Asad Ayaz, has restructured the company's global marketing leadership, creating a new enterprise team to foster collaboration and a unified brand voice across all divisions.
IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.
After a prolonged downturn, the pre-owned watch market saw a modest rebound in late 2025, driven largely by Patek Philippe and Rolex. However, a new report reveals a stark divide, with most brands still struggling with value retention as consumers pivot towards pragmatic purchases.
IDEXX Laboratories reports robust fourth-quarter and full-year 2025 results, with double-digit revenue growth fueled by record instrument placements and strategic innovations like InVue DX and CancerDx. The company provides a confident outlook for 2026, targeting continued organic growth despite sector headwinds.
Solana's leading DEX aggregator Jupiter announces a landmark integration with prediction market giant Polymarket, alongside securing a $35 million strategic investment from ParaFi Capital, signaling a major push into on-chain forecasting.
Archer Aviation secures a pivotal agreement with Serbia to supply its electric air taxis for EXPO 2027, marking a significant step into the European market and sparking discussions on its path to commercialization and valuation.
Boeing's Wichita-based engineering union has overwhelmingly approved a new labor agreement, securing substantial pay raises and improved benefits for approximately 1,600 technical staff, many recently transitioned from Spirit AeroSystems.
Dolby Laboratories (DLB) shares, closing at $64.19, present a complex picture for investors. While short-term momentum shows signs of improvement, longer-term returns have lagged, sparking debate over whether the audio technology pioneer is fundamentally undervalued or facing structural headwinds.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Swedish investment giant EQT is expanding its footprint through a strategic partnership in the private equity secondaries market with Coller Capital, while its foundation launches a science grant program targeting substitutes for critical minerals. The dual moves signal a broader strategy to tap into new fee streams and align with long-term sustainability trends, even as the firm's shares trade at levels some analysts consider undervalued.
Despite near-term headwinds in its Nutrition segment, Abbott Laboratories (ABT) maintains a bullish long-term outlook with solid organic sales growth projected for 2026, even as major analysts adjust their price targets following Q4 results.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
